The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines
Author:
Publisher
Wiley
Subject
Urology,Oncology
Reference37 articles.
1. Cancer Statistics, 2006
2. PACLITAXEL AND DOCETAXEL IN PROSTATE CANCER
3. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
4. Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
5. Multicenter Randomized Phase II Study of Two Schedules of Docetaxel, Estramustine, and Prednisone Versus Mitoxantrone Plus Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Cited by 130 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Iterativein silicoidentification of P-glycoprotein inhibitors;2024-03-07
2. Local multi-drug delivery and osteogenesis in bone metastasis of prostate cancer by a core-shell 3D printed scaffold;Journal of Drug Delivery Science and Technology;2024-02
3. Fatty Acid Synthase Inhibitors Enhance Microtubule-Stabilizing and Microtubule-Destabilizing Drugs in Taxane-Resistant Prostate Cancer Cells;ACS Pharmacology & Translational Science;2023-11-06
4. Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells;PLOS ONE;2023-10-05
5. Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells;Anti-Cancer Agents in Medicinal Chemistry;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3